PBMs made billions marking up specialty drugs by more than 1,000 percent: FTC
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
Pharma digs in on changes it wants from Trump administration
The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...
Zacks.com on MSN1d
FTC Report Reveals PBM Practices Impacting Competition and Drug Costs
The FTC study examines the practices of PBMs to ensure fair competition and transparency. The FTC found that from 2017 to 2022, the three big PBMs imposed substantial price markups on 51 specialty ...
TMCnet2h
Outcomes Matter Innovations (OMI) Appoints Senior Healthcare Executive, Paul Marchetti, to their Board of Directors
JERSEY CITY, N.J., Jan. 16, 2025 /PRNewswire/ -- Outcomes Matter Innovations, LLC ("OMI") today announced the addition of ...
Medicare rules may reduce prescription steering
Weill Cornell Medicine researchers have found that pharmacy benefit managers (PBMs)—organizations that negotiate access to ...
Le Lézard23h
Chromatin Bioscience's synthetic promoter supports EsoBiotec's ESO-T01 CAR-T therapy as it enters the clinic
Chromatin Bioscience is pleased to announce its ongoing collaboration with EsoBiotec, which has successfully advanced its ESO-T01 in vivo CAR-T candidate into clinical trials. ESO-T01 is the first in ...
hrexecutive1d
9 federal health policies that could change with the Trump administration
The new administration is likely to take significant actions that will impact employer-sponsored health insurance and federal ...
JD Supra2d
Year in Review: Top Regulatory Developments of 2024
As 2025 begins, we would like to reflect on last year’s regulatory developments in the biologics and biosimilars space. Here are ...